Publications by authors named "Jannet Beukema"

Claim this Profile
A
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer.
Famke C Wakkerman, Cathalijne C B Post, Jan Willem M Mens, Ina M Jürgenliemk-Schulz, Friederike L A Koppe, Jannet C Beukema

Maturitas· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.
Anne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, Nienke Kuijsters, Stefan Kommoss, Jannet C Beukema

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer.
Mark L Frederiks, Boudewijn van Etten, Wendy Kelder, Margriet Dieters, Jannet C Beukema

Int J Radiat Oncol Biol Phys· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial.
Isabelle Suvaal, Wilbert B van den Hout, Susanna B Hummel, Jan-Willem M Mens, Charlotte C Tuijnman-Raasveld, Jannet C Beukema

Radiother Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study.
Jannet C Beukema, Jan-Willem Haveman, Johannes A Langendijk, Edwin Oldehinkel, Alphons C M van den Bergh

Radiother Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.
Isabelle Suvaal, Susanna B Hummel, Jan-Willem M Mens, Charlotte C Tuijnman-Raasveld, Roula Tsonaka, Jannet C Beukema

Br J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study.
Jannet C Beukema, Crystal de Groot, John T M Plukker, Rozemarijn Vliegenthart, Johannes A Langendijk

Radiother Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply to Yavas et al.
Crystal Groot, Jannet C Beukema, Niek J H Prakken, Christina T Muijs

Int J Radiat Oncol Biol Phys· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.
Baukelien van Triest, Marnix Rasing, Jacobus van der Velden, Joanne de Hullu, Petronella O Witteveen, Jannet C Beukema

Gynecol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Induced Myocardial Fibrosis in Long-Term Esophageal Cancer Survivors.
Crystal de Groot, Jannet C Beukema, Johannes A Langendijk, Hans Paul van der Laan, Peter van Luijk

Int J Radiat Oncol Biol Phys· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.
Cathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, Friederike Koppe, Ina M Jürgenliemk-Schulz, Jannet C Beukema

Gynecol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical selection strategy for and evaluation of intra-operative brachytherapy in patients with locally advanced and recurrent rectal cancer.
Esmée A Dijkstra, Véronique E M Mul, Patrick H J Hemmer, Klaas Havenga, Geke A P Hospers, Jannet C Beukema

Radiother Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.
Ben M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, Berend J van der Wilk, Joel Shapiro, Jannet C Beukema

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer.
Elske M Gort, Jannet C Beukema, Witold Matysiak, Nanna M Sijtsema, Shafak Aluwini

Radiother Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?
Jannet C Beukema, Yoshifumi Kawaguchi, Nanna M Sijtsema, Tian-Tian Zhai, Johannes A Langendijk

Radiother Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.
Bo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, Maarten C C M Hulshof, Pieter van Hagen, Jannet C Beukema

J Clin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.
Karin Tamas, Urszula M Domanska, Tonnis H van Dijk, Hetty Timmer-Bosscha, Klaas Havenga, Jannet C Beukema

Curr Pharm Des· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Joel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, Pieter van Hagen, Mark I van Berge Henegouwen, Jannet C Beukema

Lancet Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac toxicity in the radiation treatment of esophageal cancer: an emerging concern.
Jannet C Beukema, Johannes A Langendijk, Christina T Muijs

Future Cardiol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?
Jannet C Beukema, Peter van Luijk, Joachim Widder, Johannes A Langendijk, Christina T Muijs

Radiother Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In reply to Gemici.
Christina T Muijs, Jannet C Beukema, Johannes A Langendijk, John Th Plukker

Int J Radiat Oncol Biol Phys· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.
A Koen Talsma, Joel Shapiro, Caspar W N Looman, Pieter van Hagen, Ewout W Steyerberg, Jannet C Beukema

Ann Surg· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.
Christina T Muijs, Jannet C Beukema, Dankert Woutersen, Veronique E Mul, Maaike J Berveling

Radiother Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study.
Anouk K Trip, Boelo J Poppema, Mark I van Berge Henegouwen, Ester Siemerink, Jannet C Beukema

Radiother Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
Vera Oppedijk, Ate van der Gaast, Jan J B van Lanschot, Pieter van Hagen, Rob van Os, Jannet C Beukema

J Clin Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis